He, Yipeng
Yin, Dandan
Wu, Zhouquan
Funding for this research was provided by:
Chinese Red Cross Foundation
Southern Medical University (2024YFC2510205)
Article History
Received: 30 August 2025
Accepted: 24 February 2026
First Online: 4 March 2026
Declarations
:
: The study was approved by the Ethics Committee of the Third Affiliated Hospital of Nanjing Medical University (Changzhou Second People's Hospital) (approval number [2023] YLJSA086) and registered with the China Clinical Trials Registry (registration number ChiCTR2500104979). All patients provided written informed consent. This trial was retrospectively registered after patient enrollment had begun, in accordance with ICMJE recommendations.
: The authors declare no competing interests.